Memorial Sloan Kettering Cancer Center
๐บ๐ธUnited States
- Country
- ๐บ๐ธUnited States
- Ownership
- Private
- Established
- 1884-01-01
- Employees
- 10K
- Market Cap
- -
- Website
- http://www.mskcc.org
BMS-247550 and Gemcitabine in Treating Patients With Advanced Solid Tumors
Phase 1
Completed
- Conditions
- First Posted Date
- 2003-01-27
- Last Posted Date
- 2008-07-24
- Lead Sponsor
- Memorial Sloan Kettering Cancer Center
- Registration Number
- NCT00043095
- Locations
- ๐บ๐ธ
Memorial Sloan-Kettering Cancer Center, New York, New York, United States
PS-341 in Treating Patients With Metastatic Kidney Cancer
Phase 2
Completed
- Conditions
- First Posted Date
- 2003-01-27
- Last Posted Date
- 2009-12-15
- Lead Sponsor
- Memorial Sloan Kettering Cancer Center
- Registration Number
- NCT00017329
- Locations
- ๐บ๐ธ
Memorial Sloan-Kettering Cancer Center, New York, New York, United States
Flavopiridol and Irinotecan in Treating Patients With Advanced Solid Tumors
Phase 1
Completed
- Conditions
- First Posted Date
- 2003-01-27
- Last Posted Date
- 2009-12-15
- Lead Sponsor
- Memorial Sloan Kettering Cancer Center
- Registration Number
- NCT00006485
- Locations
- ๐บ๐ธ
Memorial Sloan-Kettering Cancer Center, New York, New York, United States
Imatinib Mesylate and Chemotherapy in Treating Patients With Extensive-Stage Small Cell Lung Cancer
Phase 1
Completed
- Conditions
- First Posted Date
- 2003-01-27
- Last Posted Date
- 2008-07-24
- Lead Sponsor
- Memorial Sloan Kettering Cancer Center
- Registration Number
- NCT00045604
- Locations
- ๐บ๐ธ
Memorial Sloan-Kettering Cancer Center, New York, New York, United States
Huang Lian (Chinese Herb) in Treating Patients With Advanced Solid Tumors
Phase 1
Completed
- Conditions
- Interventions
- First Posted Date
- 2003-01-27
- Last Posted Date
- 2015-12-18
- Lead Sponsor
- Memorial Sloan Kettering Cancer Center
- Target Recruit Count
- 34
- Registration Number
- NCT00014378
- Locations
- ๐บ๐ธ
Memorial Sloan-Kettering Cancer Center, New York, New York, United States
Radiation Therapy Using 3-Dimensional Treatment Planning in Patients With Non-small Cell Lung Cancer
- First Posted Date
- 2003-01-27
- Last Posted Date
- 2013-11-01
- Lead Sponsor
- Memorial Sloan Kettering Cancer Center
- Target Recruit Count
- 104
- Registration Number
- NCT00002484
- Locations
- ๐บ๐ธ
Memorial Sloan-Kettering Cancer Center, New York, New York, United States
Monoclonal Antibody Therapy in Treating Patients With Prostate Cancer
Phase 2
Completed
- Conditions
- First Posted Date
- 2003-01-27
- Last Posted Date
- 2013-06-18
- Lead Sponsor
- Memorial Sloan Kettering Cancer Center
- Registration Number
- NCT00024232
- Locations
- ๐บ๐ธ
Memorial Sloan-Kettering Cancer Center, New York, New York, United States
CT Scans in Guiding the Treatment of Patients With Prostate Cancer Who Are Undergoing Radiation Therapy
Phase 2
Completed
- Conditions
- First Posted Date
- 2003-01-27
- Last Posted Date
- 2013-01-18
- Lead Sponsor
- Memorial Sloan Kettering Cancer Center
- Target Recruit Count
- 25
- Registration Number
- NCT00020891
- Locations
- ๐บ๐ธ
Memorial Sloan-Kettering Cancer Center, New York, New York, United States
Monoclonal Antibody A1G4 Plus BCG in Treating Patients With Cancer
Phase 1
Completed
- Conditions
- First Posted Date
- 2003-01-27
- Last Posted Date
- 2013-01-18
- Lead Sponsor
- Memorial Sloan Kettering Cancer Center
- Target Recruit Count
- 24
- Registration Number
- NCT00003023
- Locations
- ๐บ๐ธ
Memorial Sloan-Kettering Cancer Center, New York, New York, United States
Vaccine Therapy in Treating Patients at High Risk for Breast Cancer Recurrence
Not Applicable
Completed
- Conditions
- Interventions
- First Posted Date
- 2003-01-27
- Last Posted Date
- 2015-12-30
- Lead Sponsor
- Memorial Sloan Kettering Cancer Center
- Target Recruit Count
- 14
- Registration Number
- NCT00030823
- Locations
- ๐บ๐ธ
Memorial Sloan-Kettering Cancer Center, New York, New York, United States
ยฉ Copyright 2024. All Rights Reserved by MedPath